🦠 microbiology

Interferon-gamma induced RNF213 targets nascent double membrane vesicles to inhibit coronavirus primary translation

This study identifies interferon-gamma-induced RNF213 as a key antiviral mediator that inhibits the primary translation of diverse human coronaviruses by targeting nascent double-membrane vesicles via its ATPase and ubiquitin ligase activities, although SARS-CoV-2 appears to evade this restriction.

Original authors: Tartell, M. A., Tissawak, R., Voss, L., Lodha, M., Bianco, C., Iwamoto, M., Poston, D., Hatziioannou, T., Weisblum, Y., Bieniasz, P. D.

Published 2026-06-04

📖 3 min read☕ Coffee break read

CC BY 4.0

Original authors: Tartell, M. A., Tissawak, R., Voss, L., Lodha, M., Bianco, C., Iwamoto, M., Poston, D., Hatziioannou, T., Weisblum, Y., Bieniasz, P. D.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine your body is a fortress, and when a virus like a coronavirus tries to sneak in, your immune system sounds the alarm. One of the most powerful alarms is a signal called Interferon-gamma (or IFN- $\gamma$ ). Think of this signal as a general shouting orders to the troops inside the fortress walls, telling them to get ready for battle.

In this study, scientists acted like detectives, using a high-tech "search and destroy" tool (called a CRISPR screen) to find out exactly which soldiers in the fortress are the best at stopping these viral invaders. They were looking for specific proteins that turn on when the general shouts.

The Hero: RNF213
Among the many soldiers they found, one giant protein named RNF213 stood out as the star player. It's a massive, multi-tasking machine with two special tools:

An ATPase engine: This is like a fuel pump that gives the machine the energy to move.
A ubiquitin ligase hook: This is like a tagging gun that can mark things for disposal or change how they work.

The scientists discovered that for RNF213 to do its job, it needs both of these tools working together. If you break either one, the protein can't stop the virus.

The Battle Plan: Stopping the Virus Before It Starts
Usually, when a virus enters a cell, it tries to immediately start building copies of itself. It's like a burglar breaking into a house and immediately trying to start a factory to make more burglars.

RNF213 stops this process in a brand-new way. Instead of attacking the virus later in the process, it acts like a security guard who intercepts the blueprints the moment they are delivered.

The virus brings in its genetic instructions (the "blueprints") wrapped in a special double-layered bubble (a "double membrane vesicle").
RNF213 rushes to these bubbles, latches onto them, and physically blocks the virus from reading its own blueprints.
Specifically, RNF213 grabs onto a key viral tool called NSP3, which is the foreman responsible for setting up the virus's factory. By tagging and holding onto this foreman, RNF213 prevents the factory from ever being built.

The Result: A Mixed Bag
This protein is a tough defender against many common human coronaviruses (like the ones that cause regular colds). It effectively shuts down their ability to make new copies.

However, there is a twist. When the scientists tested this against SARS-CoV-2 (the virus that causes COVID-19), they found that this specific virus has learned to slip past the guard. SARS-CoV-2 doesn't seem to interact with RNF213, meaning this particular defense mechanism doesn't work against it.

In Summary
The paper tells us that when your body gets the "Interferon-gamma" signal, it activates a giant protein called RNF213. This protein acts like a specialized security team that grabs the virus's construction crew (NSP3) and stops them from building their factory right at the start. While this is a powerful defense against many common coronaviruses, the newer SARS-CoV-2 virus has somehow figured out how to ignore this specific guard.

Technical Summary

Problem Statement
The innate immune system utilizes various mechanisms to restrict viral replication, a process that fundamentally influences host range and viral pathogenicity. Despite the critical role of interferon-stimulated genes (ISGs) in antiviral defense, the specific molecular mechanisms by which certain ISGs inhibit human respiratory viruses, particularly coronaviruses, remain incompletely understood. There is a need to identify novel antiviral proteins that restrict the replication of human betacoronaviruses and to elucidate their precise modes of action.

Methodology
To identify proteins capable of restricting human respiratory virus replication, the authors conducted CRISPR screens targeting both type-I and type-II interferon-stimulated genes. The study focused on the human betacoronavirus HCoV-OC43 as a model system. Key experimental approaches included:

Functional Screening: Utilizing CRISPR-based loss-of-function screens to pinpoint candidate antiviral genes.
Biochemical Characterization: Assessing the enzymatic activities of the identified protein, RNF213, specifically its ATPase and ubiquitin ligase functions, to determine their necessity for antiviral activity.
Reporter Systems: Employing newly designed reporter viruses to track and analyze the specific stage of the viral life cycle affected by RNF213.
Protein Interaction Analysis: Using colocalization studies and coimmunoprecipitation to investigate physical interactions between RNF213 and viral proteins, specifically NSP3.
Comparative Analysis: Testing the efficacy of RNF213 against genetically diverse common human coronaviruses and SARS-CoV-2 to determine the breadth of its antiviral activity.

Key Contributions and Results
The study identifies Ring Finger Protein 213 (RNF213) as a key mediator of the antiviral activity of interferon-gamma (IFN $\gamma$ ) against HCoV-OC43. The primary findings include:

Mechanism of Action: RNF213 inhibits the replication of HCoV-OC43 by targeting the translation of incoming viral genomes. This represents a previously undescribed mechanism of antiviral defense.
Enzymatic Requirement: Both the ATPase and ubiquitin ligase activities of RNF213 are strictly required for its anti-HCoV-OC43 function.
Target Specificity: RNF213 colocalizes with and coimmunoprecipitates with NSP3, the primary viral translation product responsible for orchestrating the formation of coronavirus replication compartments. The authors propose that RNF213 targets nascent double membrane vesicles associated with this process.
Viral Spectrum: While RNF213 restricts a range of genetically diverse common human coronaviruses, SARS-CoV-2 appears to evade interaction with and inhibition by RNF213.

Significance
The paper claims that RNF213 serves as a critical component of the IFN $\gamma$ -mediated innate immune response against human betacoronaviruses. Its significance lies in defining a novel antiviral mechanism where a host factor directly inhibits the primary translation of viral genomes by targeting nascent double membrane vesicles and interacting with the viral protein NSP3. Furthermore, the study highlights a specific divergence in viral evasion strategies, noting that while RNF213 is effective against common human coronaviruses, SARS-CoV-2 has apparently evolved to bypass this specific restriction.

Technical Summary

More like this